These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16565483

  • 1. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury.
    Bonnans C, Fukunaga K, Levy MA, Levy BD.
    Am J Pathol; 2006 Apr; 168(4):1064-72. PubMed ID: 16565483
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells.
    Bonnans C, Gras D, Chavis C, Mainprice B, Vachier I, Godard P, Chanez P.
    Biomed Pharmacother; 2007 Jun; 61(5):261-7. PubMed ID: 17418999
    [Abstract] [Full Text] [Related]

  • 3. Commonality of defensive roles of COX-2 in the lung and gut.
    Wallace JL.
    Am J Pathol; 2006 Apr; 168(4):1060-3. PubMed ID: 16565482
    [No Abstract] [Full Text] [Related]

  • 4. Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair.
    Buchanan PJ, McNally P, Harvey BJ, Urbach V.
    Am J Physiol Lung Cell Mol Physiol; 2013 Jul 15; 305(2):L193-201. PubMed ID: 23686859
    [Abstract] [Full Text] [Related]

  • 5. Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.
    Verrière V, Higgins G, Al-Alawi M, Costello RW, McNally P, Chiron R, Harvey BJ, Urbach V.
    PLoS One; 2012 Jul 15; 7(5):e37746. PubMed ID: 22662206
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury.
    Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD.
    J Immunol; 2005 Apr 15; 174(8):5033-9. PubMed ID: 15814734
    [Abstract] [Full Text] [Related]

  • 7. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J, Ferreirós N, Pirotte B, Geisslinger G, Offermanns S.
    Biochem Pharmacol; 2013 Jun 15; 85(12):1795-802. PubMed ID: 23643932
    [Abstract] [Full Text] [Related]

  • 8. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
    Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN.
    J Immunol; 2003 Mar 01; 170(5):2688-94. PubMed ID: 12594298
    [Abstract] [Full Text] [Related]

  • 9. Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium.
    Bonnans C, Mainprice B, Chanez P, Bousquet J, Urbach V.
    J Biol Chem; 2003 Mar 28; 278(13):10879-84. PubMed ID: 12500974
    [Abstract] [Full Text] [Related]

  • 10. Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease.
    Dakin SG, Dudhia J, Werling NJ, Werling D, Abayasekara DR, Smith RK.
    PLoS One; 2012 Mar 28; 7(11):e48978. PubMed ID: 23155437
    [Abstract] [Full Text] [Related]

  • 11. Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease.
    Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, Merritt AS, Wark PA, Hutchinson A, Irving LB, Levy BD, Anderson GP.
    Proc Natl Acad Sci U S A; 2012 Jan 17; 109(3):935-40. PubMed ID: 22215599
    [Abstract] [Full Text] [Related]

  • 12. Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
    Higgins G, Buchanan P, Perriere M, Al-Alawi M, Costello RW, Verriere V, McNally P, Harvey BJ, Urbach V.
    Am J Respir Cell Mol Biol; 2014 Aug 17; 51(2):178-90. PubMed ID: 24588705
    [Abstract] [Full Text] [Related]

  • 13. A novel rat lipoxin A4 receptor that is conserved in structure and function.
    Chiang N, Takano T, Arita M, Watanabe S, Serhan CN.
    Br J Pharmacol; 2003 May 17; 139(1):89-98. PubMed ID: 12746227
    [Abstract] [Full Text] [Related]

  • 14. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.
    Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD.
    Am J Respir Crit Care Med; 2008 Sep 15; 178(6):574-82. PubMed ID: 18583575
    [Abstract] [Full Text] [Related]

  • 15. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C.
    Pharmacol Rev; 2006 Sep 15; 58(3):463-87. PubMed ID: 16968948
    [Abstract] [Full Text] [Related]

  • 16. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).
    Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN.
    Nat Med; 2002 Sep 15; 8(9):1018-23. PubMed ID: 12172542
    [Abstract] [Full Text] [Related]

  • 17. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4.
    Fang X, Abbott J, Cheng L, Colby JK, Lee JW, Levy BD, Matthay MA.
    J Immunol; 2015 Aug 01; 195(3):875-81. PubMed ID: 26116507
    [Abstract] [Full Text] [Related]

  • 18. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
    Lee HJ, Park MK, Lee EJ, Lee CH.
    Int J Biochem Cell Biol; 2013 Dec 01; 45(12):2801-7. PubMed ID: 24120851
    [Abstract] [Full Text] [Related]

  • 19. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
    Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN.
    Am J Pathol; 2001 Jan 01; 158(1):3-9. PubMed ID: 11141472
    [Abstract] [Full Text] [Related]

  • 20. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 01; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.